Eisai seeks PMDA approval for subcutaneous Leqembi in Japan
If approved, patients could self-administer a weekly dose at home as an alternative to hospital intravenous dosing.
Drug Development
MHRA approves Roche’s inavolisib for breast cancer
BeOne’s sonrotoclax gains priority FDA review for mantle cell lymphoma
Corstasis Therapeutics partners CVL for Enbumyst integration
UNICEF and Gavi to widen affordable malaria vaccine access
FDA grants accelerated approval for Otsuka’s IgAN therapy
